Navigation Links
Wiecha receives grant to study face-to-face vs. virtual health education for African-American women

(Boston) - BUSM Assistant Dean for Academic Affairs John Wiecha, MD, MPH, in the Department of Family Medicine, has received a National Institutes of Health (NIH) American Recovery & Reinvestment Act (ARRA) Challenge grant from the National Library of Medicine. The grant, valued at more than $950,000 will fund a study to provide health education to African-American women with type-2 diabetes.

The health education will be conducted either face-to-face or by using the three-dimensional virtual world, "Second Life". Participants in Second Life will create avatars, three dimensional computer representations of themselves, which they can navigate through virtual worlds. In this virtual world, patient participants will walk into buildings, sit with other patient avatars, and participate in discussions as they would in a physical world, except that they don't leave their homes or travel. Potentially this will provide more accessible health education opportunities. It is also possible that the relative anonymity of this environment will encourage patients to disclose more information about that could help them overcome barriers to healthier life styles.

"We are challenging the so-called "digital divide" that assumes that low-income patients are less able to utilize the Web for health promotion purposes," explained John Wiecha, MD, MPH. The study seeks to determine how feasible the Second Life method is for this type of health education, and how it compares to the face-to-face method."

Participants will be recruited from Boston Medical Center and BMC health centers. They will be randomly placed into groups receiving their diabetes education in face-to-face groups at BMC, or receiving it via Second Life while at home.

The online group will receive a computer and access the Internet if necessary. Both groups will participate in 12 diabetes education groups, and four individual counseling sessions. Subjects will complete surveys before and after the study to measure changes in physical activity, diet, and use of medications, and will have blood tests drawn at BMC before and after the study to measure changes in diabetes control and cholesterol. They will also have blood pressure measured before and after the study period. Dr. Wiecha is collaborating with Dr. Milagros Rosal, a Co-Principal Investigator on the project and a research health psychologist at UMASS Medical Center in Worcester.


Contact: Gina DiGravio
Boston University Medical Center

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
3. Kount Receives Patent for Device Fingerprinting
4. American College of Medical Genetics receives $13.5M NIH contract
5. Penn State receives new NASA astrobiology grant
6. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
7. Vidaza receives positve opinion from European CHMP
8. Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award
9. Montana State partnership receives $66.9M for carbon sequestration
10. Oklahoma EPSCoR receives $20 million for biofuels research
11. UC Riverside rice geneticist receives high honor from US Department of Agriculture
Post Your Comments:
(Date:6/7/2016)... 2016  Syngrafii Inc. and San Antonio Credit ... includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution ... will result in greater convenience for SACU members ... maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: